PublizoomAward notice Supplies
Raamovereenkomst voor levering van Eculizumab
Notice published in Dutch. The AI analysis summarises it for you in your language.
- Place of performance
- 9300 Aalst, East Flanders
- Amount awarded
- €2,000,000 excl. VAT
- Planned end of contract
- 27 November 2028
likely re-tender around May 2028 - Bids received
- 2
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 31 December 2024
- Notice language
- Dutch
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Opdracht betreft het sluiten van een raamovereenkomst voor het aanleveren van Eculizumab in de apotheken van het O.L.V. Ziekenhuis vzw campus Aalst en Asse.
Awarded to
- Amgen n.v. BCE/KBO 0439.652.401
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33690000
Winning prices for comparable contracts
- A quarter below
- €444,216
- Median
- €606,904
- A quarter above
- €1,514,536
Amounts awarded (excl. VAT) over the last 3 years for 27 contracts in the same CPV group (3369…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Raamovereenkomst voor het leveren van Palonosetron IV Onze-Lieve-Vrouwziekenhuis v.z.w. (met campussen te Aalst, Asse en Ninove) · 16 December 2024 |
FRESENIUS KABI NV | €365,189 |
| Raamovereenkomst voor het leveren van Epirubicine Onze-Lieve-Vrouwziekenhuis v.z.w. (met campussen te Aalst, Asse en Ninove) · 18 September 2024 |
Arega Pharma BV | €163,079 |
| SUPPLEMENTS NUTRITIONNELS ORAUX (SNO) - hypercaloriques et hyperprotéinés, avec fibres Centre Hospitalier Régional de Huy · 23 October 2026 |
Fresenius Kabi | €259,714 |
| Luspatercept VITAZ vzw · 22 October 2026 |
Orifarm Belgium | €3,000,000 |
| Raamovereenkomst voor afname van dialyseconcentraten AZ Sint-Lucas vzw · 21 October 2026 |
HEMOTECH BELUX | €1,128,000 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 801331-2024.